| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5498045 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 5 Pages |
Abstract
Survival and our ability to estimate survival in melanoma patients with brain metastases has improved significantly. The updated Melanoma-molGPA, a user-friendly tool to estimate survival, will facilitate clinical decision making regarding whether and which treatment is appropriate and will also be useful for stratification of future clinical trials. To further simplify use, a free online/smart phone app is available at brainmetgpa.com.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Paul W. MD, MPP, FASTRO, Wen MD, Paul D. MD, Steve MD, Penny MD, Daniel A. MD, Helen A. MD, Ananta MS, Ryan MS, Natalie A. MD, Kathryn MD, Emil MD, PhD, Thomas MD, William A. MS, John P. MD, PhD, Norman MD, Laurie E. MD, MBA, FASTRO, Jason K. MD, PhD,